Prohormones: their Clinical Relevance

[1]  Y. Loh,et al.  Carboxypeptidase E is a sorting receptor for prohormones: Binding and kinetic studies , 1998, Molecular and Cellular Endocrinology.

[2]  Y. Loh,et al.  Depletion of carboxypeptidase E, a regulated secretory pathway sorting receptor, causes misrouting and constitutive secretion of proinsulin and proenkephalin, but not chromogranin A. , 1998, Endocrinology.

[3]  G. Baldwin,et al.  Gastrin, gastrin receptors and colorectal carcinoma , 1998, Gut.

[4]  Anne White,et al.  ACTH precursors: biological significance and clinical relevance , 1998, Clinical endocrinology.

[5]  L. Orci,et al.  Incomplete Processing of Proinsulin to Insulin Accompanied by Elevation of Des-31,32 Proinsulin Intermediates in Islets of Mice Lacking Active PC2* , 1998, The Journal of Biological Chemistry.

[6]  N. Seidah,et al.  Proprotein Convertases , 2011, Methods in Molecular Biology.

[7]  D. Drucker.  Glucagon-Like Peptides , 1998, Diabetes.

[8]  P. Halban,et al.  Role of the Prohormone Convertase PC3 in the Processing of Proglucagon to Glucagon-like Peptide 1* , 1997, The Journal of Biological Chemistry.

[9]  B. Eaton,et al.  Distinct molecular events during secretory granule biogenesis revealed by sensitivities to brefeldin A. , 1997, Molecular biology of the cell.

[10]  P. Halban,et al.  Proinsulin Targeting to the Regulated Pathway Is Not Impaired in Carboxypeptidase E-deficientCpe fat /Cpe fat Mice* , 1997, The Journal of Biological Chemistry.

[11]  M. Castro,et al.  Prohormone and proneuropeptide synthesis and secretion. , 1997, Histology and histopathology.

[12]  P. Halban,et al.  Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon , 1997, FEBS letters.

[13]  W. Huttner,et al.  Protein secretion: Puzzling receptors , 1997, Current Biology.

[14]  S. O’Rahilly,et al.  Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene , 1997, Nature Genetics.

[15]  L. Orci,et al.  Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Steiner,et al.  Processing of Wild-type and Mutant Proinsulin-like Growth Factor-IA by Subtilisin-related Proprotein Convertases* , 1997, The Journal of Biological Chemistry.

[17]  U. Falkmer,et al.  High‐molecular weight IGF‐2 expression in a haemangiopericytoma associated with hypoglycaemia , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  M. Castro,et al.  Post-translational processing of proopiomelanocortin in the pituitary and in the brain. , 1997, Critical reviews in neurobiology.

[19]  X. Bertagna,et al.  High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors. , 1996, The Journal of clinical endocrinology and metabolism.

[20]  E. Leiter,et al.  Carboxypeptidase E Activity Is Deficient in Mice with the fat Mutation , 1996, The Journal of Biological Chemistry.

[21]  L. Fricker,et al.  Tissue Distribution and Characterization of Soluble and Membrane-bound Forms of Metallocarboxypeptidase D* , 1996, The Journal of Biological Chemistry.

[22]  T. Wang,et al.  Processing and proliferative effects of human progastrin in transgenic mice. , 1996, The Journal of clinical investigation.

[23]  J. Rothman,et al.  Protein Sorting by Transport Vesicles , 1996, Science.

[24]  M. Nauck,et al.  Hyperproinsulinemia in a three-generation Caucasian family due to mutant proinsulin (Arg65-His) not associated with imparied glucose tolerance: the contribution of mutant proinsulin to insulin bioactivity. , 1996, The Journal of clinical endocrinology and metabolism.

[25]  N. Seidah,et al.  Role of prohormone convertases in the tissue-specific processing of proglucagon. , 1996, Molecular endocrinology.

[26]  D. Ray,et al.  Impaired processing of proopiomelanocortin in corticotroph macroadenomas. , 1996, The Journal of clinical endocrinology and metabolism.

[27]  D. I. Våge,et al.  The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. , 1996, Recent progress in hormone research.

[28]  S. O’Rahilly,et al.  Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. , 1995, The New England journal of medicine.

[29]  D. Steiner,et al.  Proteolytic Processing Mechanisms in the Biosynthesis of Neuroendocrine Peptides: The Subtilisin-like Proprotein Convertases , 1995, Frontiers in Neuroendocrinology.

[30]  J. Naggert,et al.  Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity , 1995, Nature Genetics.

[31]  Y. Loh,et al.  Identification of the Sorting Signal Motif within Pro-opiomelanocortin for the Regulated Secretory Pathway (*) , 1995, The Journal of Biological Chemistry.

[32]  S. Gorr,et al.  An N‐terminal hydrophobic peak is the sorting signal of regulated secretory proteins , 1995, FEBS letters.

[33]  G. Baldwin.  Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Rhodes,et al.  What β-cell Defect Could Lead to Hyperproinsulinemia in NIDDM?: Some Clues From Recent Advances Made in Understanding the Proinsulin-Processing Mechanism , 1994, Diabetes.

[35]  M. Bain,et al.  Isolated congenital ACTH deficiency: a cleavage enzyme defect? , 1994, Clinical endocrinology.

[36]  M. F. Stewart,et al.  Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays. , 1994, The Journal of clinical endocrinology and metabolism.

[37]  D. London,et al.  ACTH precursors characterize the ectopic ACTH syndrome , 1994, Clinical endocrinology.

[38]  S. Nussey,et al.  Isolated congenital ACTH deficiency: a cleavage enzyme defect? , 1993, Clinical endocrinology.

[39]  K. Nakayama,et al.  Positional and additive effects of basic amino acids on processing of precursor proteins within the constitutive secretory pathway , 1993, FEBS letters.

[40]  R. Young,et al.  Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid. , 1993, The Journal of clinical endocrinology and metabolism.

[41]  R. Mains,et al.  The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. , 1993, The Journal of biological chemistry.

[42]  S. Arden,et al.  Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family. , 1992, The Journal of biological chemistry.

[43]  D. Steiner,et al.  A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase. , 1992, The Biochemical journal.

[44]  K. Polonsky,et al.  A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto). , 1992, The Journal of clinical investigation.

[45]  I. Lindberg.  The new eukaryotic precursor processing proteinases. , 1991, Molecular endocrinology.

[46]  W. Odell,et al.  Ectopic ACTH Secretion: A Misnomer , 1991 .

[47]  R. Mains,et al.  The tissue-specific processing of Pro-ACTH/Endorphin recent advances and unsolved problems , 1990, Trends in Endocrinology & Metabolism.

[48]  D. Steiner,et al.  Molecular cloning and sequencing of the cDNA for human membrane-bound carboxypeptidase M. Comparison with carboxypeptidases A, B, H, and N. , 1989, The Journal of biological chemistry.

[49]  R. Goodman,et al.  Amino-terminal sequences of prosomatostatin direct intracellular targeting but not processing specificity , 1989, Cell.

[50]  P. Rotwein,et al.  Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. , 1989, Endocrine reviews.

[51]  J G Ratcliffe,et al.  Direct measurement of the precursors of adrenocorticotropin in human plasma by two-site immunoradiometric assay. , 1988, The Journal of clinical endocrinology and metabolism.

[52]  J. Funder,et al.  Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. , 1988, Endocrine reviews.

[53]  G M Besser,et al.  Characterization of pro-opiomelanocortin-derived peptides in pituitary and ectopic adrenocorticotrophin-secreting tumours. , 1986, The Journal of endocrinology.

[54]  R. Kelly.  Pathways of protein secretion in eukaryotes. , 1985, Science.

[55]  D. Cook,et al.  PRO‐OPIOCORTIN RELATED PEPTIDES IN HUMAN PITUITARY AND ECTOPIC ACTH SECRETING TUMOURS , 1983, Clinical endocrinology.

[56]  S. Berson,et al.  Size heterogeneity of immunoreactive human ACTH in plasma and in extracts of pituitary glands and ACTH-producing thymoma. , 1971, Biochemical and biophysical research communications.